We are live on ! Find out more
VCP

Vernier Capital Partners Portfolio holdings

AUM $132M
1-Year Est. Return 20.75%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+20.75%
3 Year Est. Return
+75.73%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$3.01M
Cap. Flow
-$19.6M
Cap. Flow %
-8.75%
Top 10 Hldgs %
74.28%
Holding
28
New
6
Increased
5
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$7.97M
2
MSFT icon
Microsoft
MSFT
+$7.59M
3
CVS icon
CVS Health
CVS
+$2.04M
4
LYV icon
Live Nation Entertainment
LYV
+$1.38M
5
RF icon
Regions Financial
RF
+$1.13M

Sector Composition

Rank Sector Weight
1 Financials 10.88%
2 Technology 8.43%
3 Healthcare 7.86%
4 Communication Services 7.59%
5 Materials 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CALL
CVS Health
CVS
$133B
$55.8M 24.9%
708,400
+496,900
+235% +$35.5M
STZ icon
2
CALL
Constellation Brands
STZ
$22.2B
$19.4M 8.66%
+90,000
New +$19.1M
CI icon
3
CALL
Cigna
CI
$73.7B
$17.1M 7.62%
+82,000
New +$15.2M
MSFT icon
4
CALL
Microsoft
MSFT
$3.45T
$12.2M 5.44%
106,600
-143,400
-57% -$15.5M
LYV icon
5
CALL
Live Nation Entertainment
LYV
$40.6B
$12M 5.35%
220,000
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.36T
$11.7M 5.24%
194,400
+6,400
+3% +$387K
V icon
7
Visa
V
$684B
$9.65M 4.31%
64,290
-5,000
-7% -$711K
CI icon
8
Cigna
CI
$73.7B
$8.96M 4%
+43,000
New +$7.97M
CVS icon
9
CVS Health
CVS
$133B
$8.66M 3.86%
109,960
+28,544
+35% +$2.04M
MSFT icon
10
Microsoft
MSFT
$3.45T
$8.01M 3.58%
+70,030
New +$7.59M
MA icon
11
Mastercard
MA
$502B
$7.43M 3.32%
33,400
RF icon
12
Regions Financial
RF
$26.4B
$7.29M 3.25%
397,000
+60,000
+18% +$1.13M
TSLA icon
13
CALL
Tesla
TSLA
$1.23T
$6.88M 3.07%
390,000
-285,000
-42% -$5.94M
SSNC icon
14
SS&C Technologies
SSNC
$18.1B
$6.71M 2.99%
118,000
-56,469
-32% -$3.13M
LYV icon
15
Live Nation Entertainment
LYV
$40.6B
$5.26M 2.35%
96,553
+27,310
+39% +$1.38M
DLX icon
16
PUT
Deluxe
DLX
$1.18B
$4.55M 2.03%
+80,000
New +$4.82M
SHOP icon
17
Shopify
SHOP
$152B
$4.18M 1.86%
254,000
-66,000
-21% -$1.01M
SUM
18
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$3.46M 1.54%
193,582
-71,190
-27% -$1.55M
BEST
19
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$2.8M 1.25%
23,671
-18,350
-44% -$3.13M
EWZ icon
20
CALL
iShares MSCI Brazil ETF
EWZ
$9.28B
$1.05M 0.47%
+31,000
New +$1.04M
BABA icon
21
Alibaba
BABA
$293B
-41,700
Closed -$7.74M
CFG icon
22
Citizens Financial Group
CFG
$30.3B
-205,700
Closed -$8M
FL
23
PUT
DELISTED
Foot Locker
FL
-76,900
Closed -$4.05M
GE icon
24
CALL
GE Aerospace
GE
$374B
-198,229
Closed -$12.9M
QQQ icon
25
PUT
Invesco QQQ Trust
QQQ
$453B
-110,000
Closed -$18.9M

Similar funds

Vernier Capital Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Vernier Capital Partners held 28 positions worth $224M, up 1.4% from $221M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Vernier Capital Partners withdrew a net $19.6M in Q3 2018, closing 7 positions and reducing 7 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Vernier Capital Partners opened a new position in Cigna worth $8.96M.

  • Vernier Capital Partners's largest Q3 2018 buy was Cigna: 43,000 shares worth $8.96M.
  • Vernier Capital Partners added most to CVS Health in Q3 2018, an estimated $2.04M increase.
  • Vernier Capital Partners's biggest Q3 2018 reduction was SS&C Technologies, cutting an estimated $3.13M.
  • Vernier Capital Partners fully exited China Biologic Products Holdings, Inc. in Q3 2018, selling an estimated $13.1M.
  • Vernier Capital Partners's ten largest holdings make up 74% of its $224M portfolio in Q3 2018.
  • Vernier Capital Partners opened 6 new positions and closed 7 in Q3 2018.
  • Vernier Capital Partners's portfolio value rose 1.4% quarter-over-quarter to $224M.

Based on Vernier Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.